At the same time, one important indicator suggests that the price may also plummet dramatically in the foreseeable future.At the same time, one important indicator suggests that the price may also plummet dramatically in the foreseeable future.

3 Reasons Why Bitcoin (BTC) Could Climb Higher in the Short Term

2026/03/19 02:48
3 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

The leading cryptocurrency experienced a significant upswing over the past several days, with its price briefly rising to as high as $76,000.

Although it was stopped there and pushed south by $5,000, some key factors, including recent whale activity, suggest it may post further gains in the near future.

BTC Isn’t Done Yet?

Despite losing some steam in the past hours, Bitcoin remains well in the green on a weekly scale and currently trades at around $71,400 (per CoinGecko’s data). As a result, many analysts have flipped toward the optimists’ corner and expect an additional price increase.

The renowned market observer Ali Martinez, for instance, claimed that a daily close above the $73,344 resistance and later turning that level into a structural floor could open the door to a pump to $79,234 and $85,555.

In a subsequent post on X, the same analyst revealed that whales have acquired 40,000 BTC over the past seven days. The USD equivalent of the stash is almost $2.9 billion (at current rates), and now this cohort of investors controls roughly 5.17 million units, or roughly 25% of the asset’s circulating supply.

Such accumulations are generally viewed as bullish because they reduce the amount of BTC available on the open market, which, combined with non-declining demand, should lead to a price surge. They may also energize smaller players to step in and further support the upward momentum.

Next on the list is the solid interest in spot BTC ETFs lately. Over the past seven days, inflows into such investment vehicles have surpassed outflows, which is the longest such streak since October last year. When institutional investors such as pension and hedge funds increase their exposure to the asset through regulated financial vehicles, they require the issuers to purchase BTC to back their shares. Put simply, consistent ETF demand makes the remaining supply scarcer, which tends to push the price north.

Spot BTC ETFsSpot BTC ETFs, Source: SoSoValue

Despite the renewed appetite for such financial vehicles, many ETF investors remain underwater. Earlier this week, Axel Adler Jr. estimated that the $79,962 level represents the average cost basis of every BTC currently held inside these exchange-traded funds. If the asset trades below this mark, the cohort is sitting at unrealized losses, while breaking above would lead to paper profits.

Last but not least, we will touch upon the shrinking supply of BTC held on crypto exchanges. Today (March 18), the figure dropped to a new six-year low of approximately 2.72 million units. This suggests that investors continue to abandon centralized platforms in favor of self-custody methods, thereby reducing the immediate selling pressure.

BTC Exchange NetflowBTC Exchange Netflow, Source: CryptoQuant

Major Volatility Ahead?

Another industry participant who analyzed BTC’s recent performance is the X user Cantonese Cat. They claimed that the Bollinger Bands on a monthly scale have squeezed to levels never seen before.

The technical indicator shows how far the price deviates from its average, helping traders gauge volatility. When the bands tighten, it reflects a prolonged period with little turbulence: a setup that often precedes a large breakout. It is important to note that the huge move could be in any direction, or, as Cantonese Cat said:

The post 3 Reasons Why Bitcoin (BTC) Could Climb Higher in the Short Term appeared first on CryptoPotato.

Market Opportunity
Bitcoin Logo
Bitcoin Price(BTC)
$71.267,85
$71.267,85$71.267,85
-%0,28
USD
Bitcoin (BTC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26